Skip to main content

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to have publicly filed its financial results for the periods ended August 31, 2025 and November 30th, respectively. All figures are reported in Canadian dollars. The Company’s full set of Audited Financial Statements for the 2025 fiscal year, as well as its unaudited condensed interim consolidated financial statements for the first quarter of its 2026 fiscal year, and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.PharmAla.ca and its profile page on SEDAR+ at www.sedarplus.ca. “Commencing...

Continue reading

Multi Ways Holdings Reports 88% Revenue Growth in First Half 2025, Provides Corporate Updates

NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) — Multi Ways Holdings Limited (“Multi Ways” or the “Company”) (NYSE American: MWG), a leading supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region, today announces first half 2025 unaudited financial results and provides corporate updates. Management CommentaryMr. James Lim, Chairman and Chief Executive Officer of Multi Ways, is pleased to report that, “In the first half of 2025, despite a challenging and rapidly evolving business environment, the Group achieved a year-on-year increase in revenue. This growth was primarily driven by the strong performance of our equipment sales segment, reflecting the market’s confidence in our product offerings and our ability to capture new opportunities even under difficult conditions. “However,...

Continue reading

J-Long Group Limited Announces First Half 2025 Unaudited Financial Results

HONG KONG, Dec. 23, 2025 (GLOBE NEWSWIRE) — J-Long Group Limited (“JL” or the “Company”) (NASDAQ: JL), JL conducts its primary operations of apparel trims solution services in Hong Kong, today announced its unaudited financial results for the six months ended September 30, 2025. Overview:Delivers Strong First Half 2025 Results: Revenue growth by 19.3% and Adjusted EBITDA growth by 40.3% compared to the same period in 2024 Revenue was approximately US$22.7 million for the six months ended September 30, 2025, representing a strong growth of approximately 19.3% from the same period in 2024 on robust customer demand. Adjusted EBITDA was approximately US$3.9 million for the six months ended September 30, 2025, achieving 40.3% growth with the same period in 2024 (2024: approximately US$2.8 million).“We are very pleased with our strong...

Continue reading

CDT Environmental Technology Reports 2025 Unaudited Interim Financial Results and Provides Business Updates

Revenue of $7.3 million and loss per share of $0.11 impacted by reduced project activity due to a slowdown in the PRC economy SHENZHEN, China, Dec. 23, 2025 (GLOBE NEWSWIRE) — CDT Environmental Technology Investment Holdings Limited (Nasdaq: CDTG) (“CDT”, the “Company”, or “we”), a leading provider of waste treatment systems and services throughout China, today reports its unaudited interim financial results for the six months ended June 30, 2025, and provides updates on key business developments. All amounts are expressed in US dollars unless otherwise stated. 2025 Unaudited Interim Financial Results and Business UpdateRevenues decreased by approximately $5.4 million, or 42.3%, to approximately $7.3 million for the six months ended June 30, 2025, from approximately $12.7 million for the same period in 2024. The decline was driven...

Continue reading

Barnes & Noble Education Files “Super 10-K”, Reporting Full-Year Fiscal 2025 Financial Results, and Restated Financial Results for Prior Periods

Fiscal 2025 Results Consistent with Preliminary Unaudited Ranges Disclosed November 25, 2025 BNC First Day Program Revenue Increases 25% in 2025; Fall 2025 First Day Complete Enrollment Grows 24% Company Reports Total Net Debt of $94 million at End of Fiscal 2025, a $92 million Decrease Year-Over-Year Reiterates Prior Fiscal 2026 Outlook FLORHAM PARK, N.J., Dec. 23, 2025 (GLOBE NEWSWIRE) — Barnes & Noble Education, Inc. (NYSE: BNED), (“Barnes & Noble Education,” “BNED,” “the Company,” “we,” “us,” “our”), a leading solutions provider for the education industry, today announced that it has filed its Annual Report on Form 10-K, the “Super 10-K”, detailing its restatement of prior results and financial results through the fiscal year ended May 3, 2025. As previously disclosed, the Company has completed its internal investigation...

Continue reading

Results of Operations for the Three Months Ended September 30, 2025 – American Overseas Group Limited Announces Net Income Of $2.8 Million For the Three Months Ended September 30, 2025

HAMILTON, Bermuda, Dec. 22, 2025 (GLOBE NEWSWIRE) — American Overseas Group Limited BSX: AORE.BH) (Pink Sheets: AOREF.PK) (“AOG” or the “Company”) today reported consolidated net income available to common shareholders of $2.8 million, or $60.56 per diluted share, for the three months ended September 30, 2025. This compares to consolidated net income available to common shareholders of $3.4 million, or $73.42 per diluted share, for the three months ended September 30, 2024. Book value per weighted share at September 30, 2025 was $1,209.44, an increase from the book value per weighted share of $969.27 at September 30, 2024.   For the three months ended September 30, 2025, net earned property and casualty premiums decreased $1.5 million from $13.7 million a year ago to $12.2 million.    Quarter to Date fee income increased $0.2 million...

Continue reading

Apollomics Reports First Half 2025 Financial Results

FOSTER CITY, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced financial results for the first half of 2025 ended June 30, 2025. First Half 2025 Financial Results Ended June 20, 2025Cash, cash equivalents, bank deposits and money market funds as of June 30, 2025, were $2.1 million, compared to $9.8 million as of December 31, 2024. Based on current projections, the Company believes its cash position is sufficient to fund planned operations into the third quarter of 2026. Research and development (R&D) expenses were $4.6 million, including share-based compensation of $0.8 million, for the first half...

Continue reading

SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY

SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY Presentation of its Sycamore technology during a live surgical procedure Fleurieux-sur-l’Arbresle – France – December 22, 2025 – 8am – Safe (FR001400ZU25 – ALSAF) announces its sponsorship of the 12th MAMMI International Meeting, whose theme was Diagnosis and Minimally Invasive Treatment of the Spine, held in Cagliari from December 9 to 11, 2025. Chaired by Dr. Stefano Marcia, this landmark event brought together international experts to discuss the latest advances in minimally invasive spine treatment. The program included conferences, interactive sessions, and live surgical connections, allowing participants to observe the most innovative techniques in real time. Demonstration of Sycamore technology As part of this prestigious event, SAFE Orthopaedics presented its...

Continue reading

Track Group Reports Fiscal 2025 Financial Results

NAPERVILLE, Ill., Dec. 19, 2025 (GLOBE NEWSWIRE) — Track Group, Inc. (OTCQB: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its fiscal year ended September 30, 2025 (“FY25”). In FY25, the Company posted (i) total revenue of $35.2 Million (“M”), a decrease of approximately 5.0% over total revenue of $36.9M for the year ended September 30, 2024 (“FY24”); (ii) FY25 operating income of $1.2M compared to FY24 operating loss of ($1.9M); and (iii) net loss attributable to common shareholders of ($1.9M) in FY25 compared to net loss attributable to common shareholders of ($3.1M) in FY24. “While fiscal year 2025 shows a modest revenue decline largely due to the sale of our Chilean subsidiary, we delivered strong improvements across gross profit, operating income, and Adjusted EBITDA....

Continue reading

Smart Logistics Global Limited Reports First Half of 2025 Financial Results

HONG KONG, Dec. 19, 2025 (GLOBE NEWSWIRE) — Smart Logistics Global Limited (Nasdaq: SLGB) (the “Company”), a Hong Kong-based business-to-business contract logistics solution provider, today reported its financial results for the six months ended June 30, 2025. Financial highlightsRevenues for the six months ended June 30, 2025 increased 11.4% to RMB332.8 million (US$46.5 million), compared to RMB298.7 million for the same period in 2024. The increase in the Company’s revenue from the provision of transportation services was primarily attributed to the increased needs and demands from customers, which in turn was generally attributed to the economic growth in the PRC during the period. Income from operations for the six months ended June 30, 2025 was RMB8.8 million (US$1.2 million), compared to RMB0.7 million for the same period...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.